Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The CRAFFT trial has now opened sites to recruitment.

CRAFFT logo

Oxford Trauma's CRAFFT trial has received OCTRU green light and is now open to recruitment!

This study is investigating if treating a radius fracture (in children) by applying a plaster cast without an operation is just as effective as having an operation.

 

A message from the Trial Manager:

'We are delighted to announce that the CRAFFT study is open to recruitment now for 3 sites: Macclesfield, Ormskirk and Milton Keynes. Many more sites to follow.

Please visit our website at www.crafftstudy.org for more information – you will love it!'

 

Try scanning this QR code with your smartphone camera to go to the CRAFFT website!

CRAFFT QR code

Similar stories

Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease

Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.

Three NIHR HTA grants awarded to Professor Tim Theologis

Congratulations to Professor Tim Theologis, who has been awarded three NIHR HTA grants to extend research in orthopaedic disorders in children.

Going straight to surgery found to be better than undergoing rehabilitation first for longstanding anterior cruciate ligament injury

New research, funded by the National Institute for Health and Care Research (NIHR), shows initial surgery to be more successful and cost effective than undergoing treatment with rehabilitation first to treat longstanding anterior cruciate ligament injury.

Oxford receives NIHR funding to test anti-TNF on post operative delirium

Researchers at the University of Oxford have been awarded a grant from the National Institute for Health and Care Research (NIHR) to investigate whether anti-tumour necrosis factor (TNF) therapy can reduce or prevent post operative delirium/cognitive deficit.